Dr Mark Baxter is a Scottish Chief Scientist Office Clinical Academic Fellow and a Medical Oncology Registrar. He is based in the Division of Molecular and Clinical Medicine at the University of Dundee under the supervision of Professor Russell Petty. His primary research interest relates to Geriatric Oncology and optimising the care of older adults with cancer, with a specific focus on gastric and oesophageal cancer. During his PhD he is undertaking translational analysis of the GO2 trial. He is also Chair of NOTCH (National Oncology Trainees Collaborative for Healthcare Research).